1638935-72-4
1638935-72-4
Chemical Structure
Vonlerolizumab
Synonym(s): Pogalizumab; MOXR 0916
- CAS No.: 1638935-72-4
- Formula:N/A
- Molecular Weight:(145.26 kDa)
SMILES: [Vonlerolizumab]
Biological Activity: Vonlerolizumab (Pogalizumab; MOXR 0916) is a humanized IgG1 monoclonal antibody targeting OX40 (CD134). Pogalizumab partially blocks the interaction between OX40 and its natural ligand OX40L upon binding, thereby activating the NF-κB signaling pathway. Pogalizumab enhances T cell activation and proliferation and has shown antitumor activity in mouse models[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Vonlerolizumab | 99.70% | Vonlerolizumab (Pogalizumab; MOXR 0916) is a humanized IgG1 monoclonal antibody targeting OX40 (CD134). Pogalizumab partially blocks the interaction between OX40 and its natural ligand OX40L upon binding, thereby activating the NF-κB signaling pathway. Pogalizumab enhances T cell activation and proliferation and has shown antitumor activity in mouse models. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Vonlerizumab | Vonlerizumab is a CHO-expressed humanized antibody targeting TNFRSF4/OX40/CD134. Vonlerizumab carries a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145.22 kDa. The isotype control for Vonlerizumab can refer to Human IgG1 kappa, Isotype Control (HY-P99001). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
